| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NREST
|
263.50 | 3.4B | 4.11 | 11.59 | 2.18 | 106.2% | 10.3% | 84 | 83 | 464.56 | +57.2% | 84 | 0.22 |
|
STORY_B
|
105.50 | 8.2B | 3.40 | 4.24 | 2.58 | 18.4% | 9.9% | 80 | 75 | 206.69 | +71.9% | 82 | 0.35 |
|
SKIS_B
|
164.40 | 12.3B | 5.20 | 2.75 | 3.03 | 8.3% | 8.2% | 77 | 61 | 287.21 | +56.0% | 64 | 0.69 |
|
ACAD
|
96.00 | 9.2B | 2.58 | 1.40 | 2.51 | 5.2% | 6.2% | 74 | 64 | 249.03 | +119.5% | 54 | 2.12 |
|
HUM
|
69.20 | 3.3B | 4.70 | 1.06 | 3.50 | 5.1% | 6.4% | 72 | 63 | 148.37 | +85.8% | 56 | 1.45 |
|
SHOT
|
86.05 | 18.5B | 6.37 | 6.69 | 4.19 | 4.8% | 5.2% | 62 | 61 | 118.53 | +27.2% | 46 | 16.34 |
|
BETS_B
|
90.60 | 10.9B | 20.33 | 14.51 | 12.93 | 261.4% | 9.3% | 52 | 59 | 45.88 | -37.0% | 98 | 0.26 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.